Category Archives: Government

GOP Senate health bill finally unveiled; Republicans now can say at least they tried to scrap Obamacare.






A lot of Americans, including all but literally a handful of our elected representatives, have been sitting on pins and needles, waiting for the Senate to divulge its version of… Read more »

Trump’s Exec Order on drug pricing proves he’s like the leopard; he can’t change his spots






A draft of President Donald Trump’s executive order on drug prices lists several proposals to lessen regulatory hurdles for the pharmaceutical industry, reports The New York Times. Here are four things… Read more »

CAR-T Therapy: Personalized medicine with the promise of a cure; payers will decide who gets it






The News: Swiss drug giant Novartis AG has drawn widespread praise and a rising dose of controversy pertaining to its breakthrough CAR-T therapy CTL019. The medicine is under review to… Read more »

Universal health care: a “right” or “privilege.” Wrong question, or already settled?






Steve’s Take: Bloomberg’s Ramesh Ponnuru poses the question: “Is there a ‘right’ to healthcare? Our arguments about health policy frequently highlight the question.” He goes on to say that “as… Read more »

Trump offloading drug price battle to new FDA chief; Dr. Gottlieb’s ideas make a lot of sense






The News: New FDA Commissioner Dr. Scott Gottlieb comes into office immediately confronted by a host of tough challenges: from budget concerns, drug prices, staffing issues and a nationwide opioid… Read more »

Puma doubles on FDA panel’s nod for breast-cancer drug; but Swiss giant’s challenger lurks






The News: Puma Biotechnology Inc.’s (Los Angeles) experimental breast cancer drug reduces the risk of disease recurrence and should be approved, an advisory committee to the US Food and Drug… Read more »

Amgen’s osteoporosis med almost a home run in latest trial; fate now murky on heart safety






The News: Amgen Inc. (Thousand Oaks CA) and UCB SA (Brussels) no longer expect their experimental osteoporosis drug to win US approval this year after a higher rate of serious… Read more »

Abbvie’s biosimilar fight over Humira patent highlights differences between EU and US regulatory mindsets






The News: Coherus BioSciences Inc. (Redwood City CA) last week announced that the Patent Trial and Appeal Board (PTAB) of the US Patent and Trademark Office ruled in the company’s… Read more »

Surprise! GOP health bill never left the House






The News: The US House of Representatives will send its healthcare overhaul plan passed earlier this month to the Senate in a couple of weeks after it receives a final… Read more »

Senate health plan will either fine-tune Obamacare or set the clock back to 2008






Steve’s Take: Obamacare is a great, albeit imperfect, work-in-progress health program, destined to catch us up with the rest of the world where access to care is a right, not… Read more »